Compare GTX & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTX | BHC |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Switzerland | Canada |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 2.5B |
| IPO Year | 2021 | 1996 |
| Metric | GTX | BHC |
|---|---|---|
| Price | $19.13 | $5.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $20.00 | $8.33 |
| AVG Volume (30 Days) | ★ 2.4M | 1.9M |
| Earning Date | 05-25-2026 | 05-18-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | 20.63 | ★ 423.08 |
| EPS | ★ 1.52 | 0.42 |
| Revenue | $3,584,000,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $3.99 | $4.24 |
| Revenue Next Year | $4.48 | N/A |
| P/E Ratio | ★ $13.18 | $14.10 |
| Revenue Growth | ★ 3.14 | N/A |
| 52 Week Low | $7.02 | $4.28 |
| 52 Week High | $21.42 | $8.69 |
| Indicator | GTX | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.83 | 41.85 |
| Support Level | $17.41 | $5.52 |
| Resistance Level | $19.28 | $6.32 |
| Average True Range (ATR) | 0.85 | 0.29 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 38.62 | 40.24 |
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.